The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

This study has been completed.

Study NCT00152061 Information provided by Stanford University

First Received: September 8, 2005 Last Updated: September 6, 2006 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2005
Estimated Primary Completion Date:	No date given